In sports medicine, the holy grail for anterior cruciate ligament reconstruction (ACLR) is simple: less pain, faster recovery ...

Orthofix Medical, Inc. reported $203.121 million in sales and ($16,003) million in operating losses for the quarter ending ...

In June 2025, Cerapedics secured FDA premarket approval for its PearlMatrix™ P-15 Peptide Enhanced Bone Graft.

Few debates in knee arthroplasty spark as much polite-but-pointed hallway chatter as the fixation question: cemented or ...

In spine surgery, measuring success isn’t always as simple as “X-rays look straighter, job well done.” Deformity surgeons ...

A worried parent, a stoic (or not-so-stoic) child, and a pediatric back pain story that may or may not rival an epic saga.

Integra LifeSciences Holdings Corporation reported $415.6 million in sales and ($512.674) million in operating losses for the ...

CONMED’s 2Q25 numbers are in, and the picture is a mix of solid topline growth, orthopedic momentum, and some capital-market ...

A new systematic review and meta-analysis in The Journal of Bone and Joint Surgery (July 29, 2025) is asking a question that ...

According to a new meta-analysis in the July 13, 2025, Journal of Experimental Orthopaedics, you’ll need to perform somewhere ...

Stryker Corporation is in growth mode—again. In its Q2 2025 earnings call, CEO Kevin Lobo and VP of Finance and Investor ...

In an industry where everyone talks about “disrupting” spine, Demetra Holding S.p.A. might actually be doing it.